GlassScriptPhysician profile
Bobby K Mccullen
NPI 1457354284
$2,247.38
in general payments reported to CMS, 2019-2025
21 companies · $351 in 2025
The $351 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,345 · 2020: $16.55 · 2021: $70.05 · 2022: $132 · 2023: $147 · 2024: $185 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Staar Surgical Company | $1,262.44 | 2019 | |
| Alcon Vision LLC | $193.06 | 2021-2025 | Simbrinza, Luxor, Unity |
| Amgen INC. | $93.63 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $83.42 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $79.98 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $67.74 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Sun Pharmaceutical Industries INC. | $56.02 | 2022-2025 | |
| Optos, INC. | $55.04 | 2019 | |
| Abbvie INC. | $47.13 | 2022 | |
| Rayner Intraocular Lenses Limited | $43.84 | 2022-2024 | Rayone Spheric, Omidria, Rayone Aspheric |
| Allergan, INC. | $43.64 | 2019-2021 | |
| Genentech USA, INC. | $34.56 | 2022-2023 | Vabysmo |
| Biotissue Holdings INC. | $32.71 | 2022-2023 | |
| Sight Sciences, INC. | $31.83 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Regeneron Healthcare Solutions, INC. | $22.81 | 2024 | Eylea, Eylea Hd |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $21.00 | 2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $20.03 | 2022 | |
| Omeros Corporation | $17.34 | 2021 | |
| Ocular Therapeutix, INC. | $16.55 | 2020 | |
| Merz Pharmaceuticals, LLC | $13.17 | 2021 | |
| New World Medical,INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Mccullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.